BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: An Y, Gao S, Zhao WC, Qiu BA, Xia NX, Zhang PJ, Fan ZP. Transforming growth factor-β and peripheral regulatory cells are negatively correlated with the overall survival of hepatocellular carcinoma. World J Gastroenterol 2018; 24(25): 2733-2740 [PMID: 29991878 DOI: 10.3748/wjg.v24.i25.2733]
URL: https://www.wjgnet.com/1007-9327/full/v24/i25/2733.htm
Number Citing Articles
Jingwen Luo, Xu-Qiao Chen, Ping Li. The Role of TGF-β and Its Receptors in Gastrointestinal CancersTranslational Oncology 2019; 12(3): 475 doi: 10.1016/j.tranon.2018.11.010
Lisa Derosa, Cléa Melenotte, Franck Griscelli, Bertrand Gachot, Aurélien Marabelle, Guido Kroemer, Laurence Zitvogel. The immuno-oncological challenge of COVID-19Nature Cancer 2020; 1(10): 946 doi: 10.1038/s43018-020-00122-3
Ishwar Navin, Michael T. Lam, Robin Parihar. Design and Implementation of NK Cell-Based Immunotherapy to Overcome the Solid Tumor MicroenvironmentCancers 2020; 12(12): 3871 doi: 10.3390/cancers12123871
Yi-Ru Chen, Su-Shan Ouyang, Yan-Ling Chen, Ping Li, Hui-Wen Xu, Sen-Lin Zhu. BRD4/8/9 are prognostic biomarkers and associated with immune infiltrates in hepatocellular carcinomaAging 2020; 12(17): 17541 doi: 10.18632/aging.103768
Ran Yu, Linbo Jin, Fangfang Li, Manabu Fujimoto, Qiang Wei, Zhenhua Lin, Xiangshan Ren, Quanxin Jin, Honghua Li, Fanping Meng, Guihua Jin. Dihydroartemisinin inhibits melanoma by regulating CTL/Treg anti-tumor immunity and STAT3-mediated apoptosis via IL-10 dependent mannerJournal of Dermatological Science 2020; 99(3): 193 doi: 10.1016/j.jdermsci.2020.08.001
Xiu Chen, Liqiu Kou, Xiaolu Xie, Song Su, Jun Li, Yaling Li. Prognostic biomarkers associated with immune checkpoint inhibitors in hepatocellular carcinomaImmunology 2024; 172(1): 21 doi: 10.1111/imm.13751
Federico Costante, Leonardo Stella, Francesco Santopaolo, Antonio Gasbarrini, Maurizio Pompili, Tarik Asselah, Francesca Romana Ponziani. Molecular and Clinical Features of Hepatocellular Carcinoma in Patients with HBV-HDV InfectionJournal of Hepatocellular Carcinoma 2023; : 713 doi: 10.2147/JHC.S384751
Li Wu, Fu-Rong Yang, Mu-Lan Xing, Sheng-Feng Lu, Hong-Lin Chen, Qiao-Wei Yang, Yu-Ting Zhang, Yin Lu, Yan Huang. Multi-material basis and multi-mechanisms of the Dahuang Zhechong pill for regulating Treg/Th1 balance in hepatocellular carcinomaPhytomedicine 2022; 100: 154055 doi: 10.1016/j.phymed.2022.154055
Aswathy R Devan, Keechilat Pavithran, Bhagyalakshmi Nair, Maneesha Murali, Lekshmi R Nath. Deciphering the role of transforming growth factor-beta 1 as a diagnostic-prognostic-therapeutic candidate against hepatocellular carcinomaWorld Journal of Gastroenterology 2022; 28(36): 5250-5264 doi: 10.3748/wjg.v28.i36.5250
Caecilia H C Sukowati, Korri Elvanita El-Khobar, Claudio Tiribelli. Immunotherapy against programmed death-1/programmed death ligand 1 in hepatocellular carcinoma: Importance of molecular variations, cellular heterogeneity, and cancer stem cellsWorld Journal of Stem Cells 2021; 13(7): 795-824 doi: 10.4252/wjsc.v13.i7.795
Christine Ménétrier-Caux, Isabelle Ray-Coquard, Jean-Yves Blay, Christophe Caux. Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?Journal for ImmunoTherapy of Cancer 2019; 7(1) doi: 10.1186/s40425-019-0549-5
David J. Pinato, Nadia Guerra, Petros Fessas, Ravindhi Murphy, Takashi Mineo, Francesco A. Mauri, Sujit K. Mukherjee, Mark Thursz, Ching Ngar Wong, Rohini Sharma, Lorenza Rimassa. Immune-based therapies for hepatocellular carcinomaOncogene 2020; 39(18): 3620 doi: 10.1038/s41388-020-1249-9
Kendi Nishino Miyamoto, Diego Bonatto. Circulating cells and exosomes in acute myelogenous leukemia and their role in disease progression and survivalClinical Immunology 2020; 217: 108489 doi: 10.1016/j.clim.2020.108489